Induction of apoptosis and caspase activation in cells obtained from familial haemophagocytic lymphohistiocytosis patients.
about
Spectrum of perforin gene mutations in familial hemophagocytic lymphohistiocytosisPathogenesis of haemophagocytic lymphohistiocytosis.Recent developments in the management of haemophagocytic lymphohistiocytosis.Familial hemophagocytic lymphohistiocytosis: too little cell death can seriously damage your health.Biology and treatment of familial hemophagocytic lymphohistiocytosis: importance of perforin in lymphocyte-mediated cytotoxicity and triggering of apoptosis.Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocolPerforin and lymphohistiocytic proliferative disorders.Mitochondrial nitric oxide in the signaling of cell integrated responses.Case report: patient with unexplained high fever and pancytopenia.Engraftment and dissemination of T lymphocytes from primary haemophagocytic lymphohistiocytosis in scid mice.Etoposide selectively ablates activated T cells to control the immunoregulatory disorder hemophagocytic lymphohistiocytosis.Spectrum and clinical implications of syntaxin 11 gene mutations in familial haemophagocytic lymphohistiocytosis: association with disease-free remissions and haematopoietic malignancies.Frequency and spectrum of central nervous system involvement in 193 children with haemophagocytic lymphohistiocytosis.Hemophagocytic lymphohistiocytosis complicated by multiorgan failure: A case report.Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study.Subtyping of natural killer cell cytotoxicity deficiencies in haemophagocytic lymphohistocytosis provides therapeutic guidance
P2860
Q24536183-D8606DAC-9569-4BB5-8197-CD599B886280Q34374227-392C1147-A789-4B97-9DC2-84880E8C92D7Q34390355-CB7B5E43-D405-49F0-BE87-631C557F8182Q34431456-6F5A1D4D-5271-47FC-9BC3-8B0936C3403FQ34616808-63B32E25-7EF3-4B9B-B56C-93C69D76302DQ35525318-ED80E2B3-2116-4F3E-B040-116EF8D02B8DQ36065181-CD272BEF-7F46-41AE-BC62-03BD23CF0DF1Q36818954-BEA54402-B12F-45FA-9D17-B4FC4C9AD143Q40056319-B854B912-4971-424B-A7A6-A57D698DA851Q40655640-A268798F-C6F2-4247-8028-FDD49CE42E70Q41831996-42C84D69-E948-4CBB-B4A3-AAB3E2B23120Q43146519-1D17BA06-C25D-4E04-9A49-400327E39633Q46852944-14CB8E79-D1E7-486B-994A-597A1E510645Q47640485-A43D248F-3CC6-4375-A4F9-FECBADE2F0A9Q47945740-F2B0644A-D235-4E65-9B01-7807373439A6Q57697882-02B97911-ACE1-49E6-A995-6DAA74E5CEB3
P2860
Induction of apoptosis and caspase activation in cells obtained from familial haemophagocytic lymphohistiocytosis patients.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Induction of apoptosis and cas ...... lymphohistiocytosis patients.
@en
type
label
Induction of apoptosis and cas ...... lymphohistiocytosis patients.
@en
prefLabel
Induction of apoptosis and cas ...... lymphohistiocytosis patients.
@en
P2860
P1476
Induction of apoptosis and cas ...... lymphohistiocytosis patients.
@en
P2093
P2860
P304
P356
10.1046/J.1365-2141.1999.01538.X
P407
P577
1999-08-01T00:00:00Z